✦ LIBER ✦

A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)

✍ Scribed by Middleton, Gary; Brown, Sarah; Lowe, Catherine; Maughan, Timothy; Gwyther, Stephen; Oliver, Alfred; Richman, Susan; Blake, Denise; Napp, Vicky; Marshall, Helen; Wadsley, Jonathan; Maisey, Nick; Chau, Ian; Hill, Mark; Gollins, Simon; Myint, Sun; Slater, Sarah; Wagstaff, John; Bridgewater, John; Seymour, Matthew

Book ID: 122929122
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 614 KB
Volume: 49
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2013.06.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6097 POSTER Ciclosporin in Combination W

6097 POSTER Ciclosporin in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer – Results of PICCOLO, a Large Randomised Trial With Prospective Molecular Stratification

✍ Middleton, G.W.; Brown, S.R.; Gwyther, S.J.; Maughan, T.S.; Wadsley, J.; Chau, I 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 65 KB

6007 ORAL Panitumumab in Combination Wit

6007 ORAL Panitumumab in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer: Results of PICCOLO, a Large Randomised Trial With Prospective Molecular Stratification

✍ Seymour, M.T.; Brown, S.R.; Richman, S.; Middleton, G.W.; Maughan, T.S.; Maisey, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

598 ORAL Randomised comparison of 5-FU/f

598 ORAL Randomised comparison of 5-FU/folinic acid plus irinotecan (FOLFIRI) and irinotecan plus oxaliplatin (IROX) in first-line therapy of metastatic colorectal cancer (CRC): the fire-trial

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

1090 Continuation of irinotecan (CPT-11)

1090 Continuation of irinotecan (CPT-11) beyond 8 cycles does not improve outcome in patients with advanced colorectal cancer resistant to fluoropyrimidines: results of a phase III multi-centre randomised trial

✍ Dickson, J.L.B.; Lal, K.R.; Norman, A.R.; Ross, P.J.; Oates, J.; Massey, A.; Hil 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 164 KB

A meta-analysis of two Irinotecan-based

A meta-analysis of two Irinotecan-based phase III randomized trials for the efficacy and treatment tolerance in older patients with Metastatic Colorectal Cancer (MCRC)

✍ Vamvakas, L.; Karampeazis, A.; Boukovinas, I.; Kakolyris, S.; Polyzos, A.; Ninto 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 46 KB

599 ORAL Improved activity with irinotec

599 ORAL Improved activity with irinotecan, oxaliplatin and infusional 5-FU/LV (FOLFOXIRI) compared with FOLFIRI in metastatic colorectal cancer (MCRC): results of a randomized phase III trial by the Gruppo Oncologico Nord Ovest (G.O.N.O.)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 262 KB